SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-24-172221
Filing Date
2024-06-28
Accepted
2024-06-28 16:01:27
Documents
4
Period of Report
2024-08-12

Document Format Files

Seq Description Document Type Size
1 PRE 14A d787209dpre14a.htm PRE 14A 212204
2 GRAPHIC g787209g01g01.jpg GRAPHIC 214356
3 GRAPHIC g787209g02g02.jpg GRAPHIC 224833
4 GRAPHIC g787209g53p02.jpg GRAPHIC 35870
  Complete submission text file 0001193125-24-172221.txt   868055
Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Filer) CIK: 0001796129 (see all company filings)

IRS No.: 833197402 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39244 | Film No.: 241085480
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)